DSIP

Delta sleep-inducing peptide has the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. It carries no terminal modification and no cysteine. Two acidic residues against no basic residue make it a strongly anionic peptide, and four of its nine positions are glycine or alanine, giving a flexible backbone with little defined secondary structure in solution.

It was originally isolated from cerebral venous blood of rabbits during electrically induced sleep, which is the origin of the name. That name describes the circumstances of its discovery rather than an established function, and reading it as a mechanism is a common error with this compound.

No dedicated receptor has been characterised for it in the intervening decades, despite sustained effort. This is the central fact about the molecule: the literature describes correlations and pathway-level observations across several neurotransmitter and neuroendocrine systems without a defined binding target to anchor them.

Electrophysiological work in rabbit and rat preparations, measuring electroencephalographic spectral power in the delta band, forms the classical body of evidence. Later work reports interactions with opioidergic and glutamatergic signalling and effects on oxidative stress markers in tissue preparations.

A methodological caveat runs through the older literature and deserves stating plainly. Much of the early tissue work relied on immunoassay with antisera raised against the peptide, and what those assays detected was described as delta sleep-inducing peptide-like immunoreactivity rather than the peptide itself. Cross-reactivity of such antisera is a known limitation, and the distinction between the immunoreactive signal and the identified nonapeptide matters when interpreting the reported distribution of this molecule in tissue.

The N-terminal tryptophan gives strong absorbance at 280 nanometres, which makes ultraviolet detection straightforward and provides a useful secondary confirmation channel alongside the peptide bond signal at 214 nanometres.

The impurity that matters cannot be seen by mass spectrometry. Positions five and six are aspartate followed by glycine, the sequence motif most prone to succinimide formation and subsequent isoaspartate rearrangement, because glycine offers no side chain to hinder the cyclisation. The resulting isoaspartyl peptide has an identical molecular formula and an identical mass, while carrying an extra methylene in the backbone that changes its conformation.

Only chromatography separates the two, and the rearrangement accelerates at alkaline pH and elevated temperature. A lot analysis for this peptide should therefore resolve the isoaspartyl form rather than report a single peak, and the same chemistry sets the storage conditions below.